Literature DB >> 11504884

Conditional cell ablation by stringent tetracycline-dependent regulation of barnase in mammalian cells.

S Leuchtenberger1, A Perz, C Gatz, J W Bartsch.   

Abstract

Conditional expression of suicide genes in vivo has a wide range of applications in biological research and requires a minimal basal promoter activity in the uninduced state. To reduce basal activity of tetracycline (tc)-inducible target promoters we combined synthetic tet operators in varying numbers with a core promoter derived from the plant viral 35S promoter. An optimized promoter, P(TF), was found to exert a stringent regulation of luciferase in combination with tTA and rtTA in different mammalian cell lines. We linked P(TF) to the barnase gene, coding for a highly active RNase from Bacillus amyloliquefaciens. Stable cell clones expressing barnase under control of tTA exerted cell death only after tc withdrawal, correlating with a 10-fold induction of barnase mRNA expression. Directing tTA expression through a neuron-specific enolase promoter (P(NSE)) leads to barnase expression and cell death in neuronal cells after tc withdrawal. Taken together, our data demonstrate that a stringent control of barnase expression in the uninduced state improves cell ablation studies, as high frequencies of transgene propagation in both cell lines and in transgenic mice are observed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11504884      PMCID: PMC55860          DOI: 10.1093/nar/29.16.e76

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  20 in total

1.  A regulatory network for the efficient control of transgene expression.

Authors:  M O Imhof; P Chatellard; N Mermod
Journal:  J Gene Med       Date:  2000 Mar-Apr       Impact factor: 4.565

2.  Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.

Authors:  M Gossen; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-15       Impact factor: 11.205

3.  A novel cell ablation strategy blocks tobacco anther dehiscence.

Authors:  T P Beals; R B Goldberg
Journal:  Plant Cell       Date:  1997-09       Impact factor: 11.277

4.  Transgenic mice expressing beta-galactosidase in mature neurons under neuron-specific enolase promoter control.

Authors:  S Forss-Petter; P E Danielson; S Catsicas; E Battenberg; J Price; M Nerenberg; J G Sutcliffe
Journal:  Neuron       Date:  1990-08       Impact factor: 17.173

5.  Tetracycline-controlled expression but not toxicity of an attenuated diphtheria toxin mutant.

Authors:  K Keyvani; I Baur; W Paulus
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

6.  Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice.

Authors:  A Kistner; M Gossen; F Zimmermann; J Jerecic; C Ullmer; H Lübbert; H Bujard
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

7.  Dicistronic transcription units for gene expression in mammalian cells.

Authors:  W Dirks; M Wirth; H Hauser
Journal:  Gene       Date:  1993-06-30       Impact factor: 3.688

8.  Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter.

Authors:  P A Furth; L St Onge; H Böger; P Gruss; M Gossen; A Kistner; H Bujard; L Hennighausen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

9.  Transcriptional activation by tetracyclines in mammalian cells.

Authors:  M Gossen; S Freundlieb; G Bender; G Müller; W Hillen; H Bujard
Journal:  Science       Date:  1995-06-23       Impact factor: 47.728

10.  Hormone induces binding of receptors and transcription factors to a rearranged nucleosome on the MMTV promoter in vivo.

Authors:  M Truss; J Bartsch; A Schelbert; R J Haché; M Beato
Journal:  EMBO J       Date:  1995-04-18       Impact factor: 11.598

View more
  9 in total

Review 1.  Killing of cancer cells through the use of eukaryotic expression vectors harbouring genes encoding nucleases and ribonuclease inhibitor.

Authors:  Elena M Glinka
Journal:  Tumour Biol       Date:  2015-04-01

Review 2.  Molecular neuroanatomy's "Three Gs": a primer.

Authors:  Susan M Dymecki; Jun Chul Kim
Journal:  Neuron       Date:  2007-04-05       Impact factor: 17.173

3.  Modular enzyme design: regulation by mutually exclusive protein folding.

Authors:  Jeung-Hoi Ha; James S Butler; Diana M Mitrea; Stewart N Loh
Journal:  J Mol Biol       Date:  2006-02-06       Impact factor: 5.469

4.  Modulating Protein Stability to Switch Toxic Protein Function On and Off in Living Cells.

Authors:  Frederik Faden; Stefan Mielke; Nico Dissmeyer
Journal:  Plant Physiol       Date:  2019-01-24       Impact factor: 8.340

5.  Bigenic Cre/loxP, puDeltatk conditional genetic ablation.

Authors:  You-Tzung Chen; Regis Levasseur; Sukeshi Vaishnav; Gerard Karsenty; Allan Bradley
Journal:  Nucleic Acids Res       Date:  2004-11-23       Impact factor: 16.971

6.  Structural and thermodynamic analysis of a conformationally strained circular permutant of barnase.

Authors:  James S Butler; Diana M Mitrea; Gregory Mitrousis; Gino Cingolani; Stewart N Loh
Journal:  Biochemistry       Date:  2009-04-21       Impact factor: 3.162

7.  Heterogeneous inducible mammary-specific expression of Jab/SOCS1 in lactating transgenic mice is associated with no obvious phenotype, even at the cellular level.

Authors:  Barbara Petridou; Solange Soulier; Nathalie Besnard; Marthe Hudrisier; Catherine Hue-Beauvais; José Costa Da Silva; Jean Djiane; Jean-Luc Vilotte
Journal:  Transgenic Res       Date:  2003-12       Impact factor: 2.788

Review 8.  Barnase-Barstar Pair: Contemporary Application in Cancer Research and Nanotechnology.

Authors:  Olga Shilova; Polina Kotelnikova; Galina Proshkina; Elena Shramova; Sergey Deyev
Journal:  Molecules       Date:  2021-11-10       Impact factor: 4.411

9.  Barnase as a new therapeutic agent triggering apoptosis in human cancer cells.

Authors:  Evelina Edelweiss; Taras G Balandin; Julia L Ivanova; Gennady V Lutsenko; Olga G Leonova; Vladimir I Popenko; Alexander M Sapozhnikov; Sergey M Deyev
Journal:  PLoS One       Date:  2008-06-18       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.